Clinical Trial Update: Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated a parenteral nutrition regimen containing omega-3 fatty acids in gastrointestinal cancer patients after GI surgery, reporting efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Parenteral nutrition regimen with omega-3 fatty acids (omega-3 fatty acids in parenteral nutrition)

Snippet

Sponsor: B. Braun Melsungen AG | Conditions: GI Cancer | Phase 3 | Status: COMPLETED